<DOC>
	<DOCNO>NCT02599116</DOCNO>
	<brief_summary>This study analyze gastrointestinal microbiome appendiceal cancer patient peritoneal spread schedule undergo cytoreductive surgery hyperthermic intraperitoneal chemotherapy ( CRS/HIPEC ) . Participants provide fecal sample pre- post-operatively .</brief_summary>
	<brief_title>Gastrointestinal Microbiome Study Appendiceal Cancer</brief_title>
	<detailed_description>Analysis human microbiome attempt define change human microbiome associate health disease . Eligible participant schedule undergo cytoreductive surgery hyperthermic intraperitoneal chemotherapy ( CRS/HIPEC ) appendiceal cancer provide fecal sample pre- post-operatively . Investigators analyze potential change gastrointestinal microbiome make comparison age-matched healthy sample .</detailed_description>
	<mesh_term>Pseudomyxoma Peritonei</mesh_term>
	<mesh_term>Appendiceal Neoplasms</mesh_term>
	<criteria>Diagnosis appendiceal cancer peritoneal spread Candidate cytoreductive surgery hyperthermic intraperitoneal chemotherapy ( CRS/HIPEC ) ≥18 ≤ 80 year age Eastern Cooperative Oncology Group performance status score ≤2/Karnofsky performance status ( KPS ) ≥70 % Signed Institutional Review Board approve inform consent &lt; 18 year age Pregnant woman Concurrent severe medical problem unrelated malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cytoreductive surgery</keyword>
	<keyword>hyperthermic intraperitoneal chemotherapy</keyword>
	<keyword>microbiome</keyword>
</DOC>